Access Bio Inc
Access Bio, Inc. engages in the research, development, and manufacture of in vitro rapid diagnostic tests, biosensors, and molecular diagnostic products worldwide. The company provides Covid-19 detection kits, which are tests for assessing the current or past presence of SARS-CoV-2.; rapid diagnostic tests, suitable for preliminary diagnosis or emergency medical screening in medical facilities wi… Read more
Access Bio Inc (950130) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.015x
Based on the latest financial reports, Access Bio Inc (950130) has a cash flow conversion efficiency ratio of -0.015x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-9.16 Billion) by net assets (₩599.93 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Access Bio Inc - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how Access Bio Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Access Bio Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Access Bio Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Iljin Holdings
KO:015860
|
-0.065x |
|
Totens Sparebank
OL:TOTG
|
-0.004x |
|
Sparebanken Ost
OL:SPOG
|
0.022x |
|
BayWa AktienGesellschaft Vink.N
F:BYW6
|
-0.099x |
|
Solteam Electronics Co Ltd
TWO:3484
|
0.019x |
|
Hansol Paper Co Ltd
KO:213500
|
-0.001x |
|
Papilon Savunma Guvenlik Sistemleri
IS:PAPIL
|
-0.031x |
|
Renascor Resources Ltd
AU:RNU
|
0.003x |
Annual Cash Flow Conversion Efficiency for Access Bio Inc (2012–2024)
The table below shows the annual cash flow conversion efficiency of Access Bio Inc from 2012 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩442.28 Million | ₩13.54 Million | 0.031x | +22410.95% |
| 2023-12-31 | ₩587.14 Billion | ₩-80.57 Million | 0.000x | -100.02% |
| 2022-12-31 | ₩487.74 Million | ₩291.33 Million | 0.597x | +4.71% |
| 2021-12-31 | ₩241.75 Million | ₩137.90 Million | 0.570x | -99.88% |
| 2020-12-31 | ₩76.95 Million | ₩36.72 Billion | 477.222x | +2498.24% |
| 2019-12-31 | ₩21.22 Million | ₩-422.24 Million | -19.899x | +88.40% |
| 2018-12-31 | ₩33.42 Million | ₩-5.73 Billion | -171.471x | -29.50% |
| 2017-12-31 | ₩41.13 Million | ₩-5.45 Billion | -132.408x | -298039.61% |
| 2016-12-31 | ₩47.55 Million | ₩2.11 Million | 0.044x | +19.26% |
| 2015-12-31 | ₩76.88 Billion | ₩2.87 Billion | 0.037x | +197.03% |
| 2014-12-31 | ₩68.58 Billion | ₩-2.63 Billion | -0.038x | -221.48% |
| 2013-12-31 | ₩50.20 Billion | ₩1.59 Billion | 0.032x | -62.82% |
| 2012-12-31 | ₩21.71 Billion | ₩1.85 Billion | 0.085x | -- |